Prescription weight loss drugs have become so popular in the United States that suppliers have struggled to keep up.

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

In late June, generic drug maker Teva Pharmaceuticals launched a generic version of Victoza, a blockbuster diabetes drug, in ...

Victoza is one of the first GLP-1 drugs — the class of wildly popular diabetes and obesity treatments that includes Ozempic ...

A research team has found that lateral septum (LS) neurons play a crucial role in the anorectic and weight-lowering effects of liraglutide in mice, revealing that GLP-1 receptors in the LS mediate ...

Late last year, Novo Nordisk responded to a growing shortage of popular Ozempic with a plan to cut down on production of its older diabetes med Victoza to make room for more Ozempic. Still ...

Biotechnology firm Biocon said its subsidiary has received approval from the US health regulator to market a generic medication to treat chronic heart failure. Biocon Pharma has received approval of ...

Semaglutide – but not liraglutide – is associated with disproportionately increased reporting of suicidal ideation, according to study results published in JAMA Network. To this aim ...

In a recent study published in JAMA Network Open, researchers investigate the potential link between the obesity drugs semaglutide and liraglutide and suicidal or self-injurious adverse drug ...